Pediatric low-grade glioma in the era of molecular diagnostics.
Ryall S, Tabori U, Hawkins C. · 2020
Read Pediatric low-grade glioma in the era of molecular diagnostics. by Ryall S, Tabori U, Hawkins C. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7066826.txt.
Introduction
Ryall, Tabori, and Hawkins review childhood low-grade glioma in Acta Neuropathologica Communications. Low-grade gliomas are the most common brain tumours in children. They differ sharply from adult versions in their genetic faults and rarely transform into high-grade tumours. Yet children whose tumours cannot be fully removed often suffer repeated growth, with mounting harm and sometimes death.
A near-universal feature of these tumours is overactivation of the RAS/MAPK signalling pathway. That discovery has produced targeted drugs meant to work better while sparing children the toll of chemotherapy. The review explains how molecular testing refines the many tumour types under the low-grade umbrella, describes the specific drivers, and details how to test for them. It then assesses the newest agents and proposes a risk stratification system combining clinical and molecular features, so treatment intensity can match each child's actual danger.
Catalog record
| CREATOR | Ryall S, Tabori U, Hawkins C. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 111 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |